SMT Research

Sahajanand Medical Technologies (SMT) is a leading global medical device company focused on the design, development, and manufacturing of minimally invasive cardiovascular devices. Headquartered in India, the company is best known for its extensive portfolio of drug-eluting stents (DES), including the Supraflex and Firehawk series, which are used to treat coronary artery disease. SMT maintains a strong commitment to clinical research, frequently conducting large-scale trials such as the TALENT and FIREHAWK studies to validate the safety and efficacy of its products. The company operates advanced manufacturing facilities and serves healthcare providers in over 75 countries worldwide. Beyond coronary stents, SMT is expanding its offerings into structural heart and peripheral vascular interventions.